U.S. GAO Calls for Device Recall Oversight Reform by FDA

July 20, 2011
The U.S. Food and Drug Administration (FDA) should launch a program to routinely and systematically assess device recall information, and use this program to identify strategies for mitigating health risks presented by defective or unsafe devices, the U.S. Government Accountability Office (GAO) says.
International Medical Device Regulatory Monitor